Proof of Candidate
Finding talent for late stage neuroscience drug development
At a recent OBN/One Nucleus BioTuesday focusing on neurodegenerative diseases, I heard again the extent of the challenge faced by scientists wanting to develop...
Hiring international executives and the (true) costs of failure
A tale of two …points of view? “It was the best of times, it was the worst of times, it was the age of...
Behavioural profiling in the search for medical affairs professionals
In pharmaceutical companies, medical affairs professionals play a vital yet complex role: acting as a bridge between the medical and commercial groups, and as...
Ipsen choose RSA Group as strategic partner for executive talent acquisition in Europe
We have been selected by Ipsen, one of the world’s leading innovators in patient care, as their chosen strategic partner in Europe for executive...
Avoid firing through better hiring
Luke Johnson, the serial entrepreneur and investor made a critical insight in his recent column in the Sunday Times. He wrote about how difficult and costly it...
Due diligence needed in exec hiring: the difference between success and failure
We recently showed the cost of making bad senior hires, with 48% going wrong in the first 18 months. To remind you of the enormity of...
Hiring new talent – it pays to be diligent
Companies hire new senior talent to fuel corporate success. Too often it proves to be an expensive failure. New data from Leadership IQ1 across...